Due to the frequent rejection of claims for noninvasive ventilators by Medicare Advantage plans, individuals with amyotrophic lateral sclerosis (ALS) are experiencing disproportionately high rates of hospital admissions.
Due to the frequent rejection of claims for noninvasive ventilators (NIVs) by Medicare Advantage plans, individuals with amyotrophic lateral sclerosis (ALS) are experiencing disproportionately high rates of hospital admissions for inpatient care. Jeffrey Sippel, MD, MPH, associate director of inpatient clinical services and associate professor of clinical medicine in the Pulmonary Sciences & Critical Care Medicine Division at the University of Colorado School of Medicine, highlighted this issue in an interview with the American Journal of Managed CareⓇ (AJMCⓇ).
Transcript
What has been the impact of these denials on patients with ALS and their families, considering the urgency of their medical needs?
I think the impact of this type of approach from the insurance companies, I think it's had a huge impact on our patients and the families. What we like to do is provide relatively seamless care for these very, very complex patients. Here's how I would define seamless care: Three to 5 to 6 years ago, if we had a patient who had imminent need for support, we could actually get it arranged within 24 hours. There are even times where we saw a patient on Friday and had support arranged for them at home by Saturday. That is super cool, and it is super good.
And so when you have that as what's achievable, and what's doable, and then you fall back to having to wait days to weeks or longer, secondary to denials and appeals, then the most important thing is that it delays life-saving care for these patients, number 1. Number 2, we sometimes have to admit them to the hospital, which is a big wildcard and it's a big disruption for them. And then number 3, the family and the support. They want these patients at home, they want to love the heck out of them. And when there are delays in care and they watch their loved one going downhill without support or have to get admitted to the hospital, that's just a really complicated thing. Unfortunately, a lose-lose is really what it's been on this.
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Neurologists Share Tips for Securing Patient Access to Gene Therapies
March 19th 2025Tenacious efforts at every level, from the individual clinician to the hospital to the state to Congress, will be needed to make sure patients can access life-saving gene therapies for neuromuscular diseases.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
How Access to SMA Treatment Varies Globally and by Insurance Type
March 18th 2025Posters presented at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference show that therapeutic advances in treating spinal muscular atrophy (SMA) are not uniformly making it into the hands of patients who could benefit.
Read More